GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 68 days ( 0 % )
Last Price $0.0006 0 %
High/ Low $0.0006 - $0.0006 0%
Chg 7 Days N/A $0.0006 $0.0006
Chg 30 Days N/A $0.0006 $0.0006
Chg 12 mos -99.24 % $0.0788 $0.0006
Trend - 3 mos 8.03 % Width: 328.97 %
Trend - 12 mos -19.67 % Width: 541.45 %
Pred. range - 3 mos $0.0002 - $0.0007 -73.56 % - 13.42 %
Pred. range - 12 mos N/A - $0.0517 -100.00 % - 8,510.06 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2022-10-24 - 73 days
Long MA avg 12 mos Sell 2022-09-13 - 102 days
Short/Long MA avg 12 mos Sell 2022-09-22 - 95 days
Pivot Short Sell 2023-02-06 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Generex Biotechnology Corp

Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors ... GNBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT